Eric Swayze sold $2K of IONS stock

Eric Swayze, EVP Research of Ionis Pharmaceuticals Inc (IONS), sold 53 shares of IONS stock worth $2K, per an SEC Form 4 filed Oct 20, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Oct 15, 2026, 5 days before it was made public.

IONS has moved -38.1% since the trade date, from $44.12 to $27.31 (Nov 12, 2026 close).